WAM
OCUL icon

Weiss Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Weiss Asset Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-187,615
Closed -$1.74M – 729
2025
Q2 		$1.74M Buy
+187,615
New +$1.47M 0.02% 263

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Weiss Asset Management's OCUL Position: Q3 2025 in Review

Weiss Asset Management sold out of Ocular Therapeutix (OCUL) in Q3 2025, closing a stake of 187,615 shares — an estimated $1.74M sold.

Weiss Asset Management first reported a position in OCUL in Q2 2025 and held it in 1 quarter. The position peaked at $1.74M in Q2 2025. 216 funds tracked by Wall St. Rank hold OCUL as of Q3 2025.

  • Weiss Asset Management reported no remaining Ocular Therapeutix position as of Q3 2025 after selling out during the quarter.
  • Weiss Asset Management sold 187,615 Ocular Therapeutix shares in Q3 2025, an estimated $1.74M.
  • Weiss Asset Management first reported a position in Ocular Therapeutix in Q2 2025 and held it in 1 quarter.
  • Weiss Asset Management's Ocular Therapeutix position peaked at $1.74M in Q2 2025.
  • 216 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2025.

Based on Weiss Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.